| Additive Effect of Probiotics (Mutaflor®) in Patients With Ulcerative Colitis on 5-ASA Treatment. (NCT04969679) | Kangbuk Samsung Hospital | 2018-03-16 |
| Phase 2 Dose-finding IMU-838 for Ulcerative Colitis (NCT03341962) | Immunic AG | 2018-03-15 |
| Sick Leave, Work Disability and Quality of Life in Korean Patients With Inflammatory Bowel Diseases (NCT03565432) | Kyunghee University Medical Center | 2018-03-09 |
| A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) (NCT03283085) | Shire | 2018-02-27 |
| Fecal Microbiota Transplantation (FMT) in the Treatment of Pouchitis (NCT03378921) | Helsinki University Central Hospital | 2018-02-27 |
| A Study to Evaluate the Safety of PRV-300 in Adult Subjects With Moderately to Severely Active Ulcerative Colitis (NCT03849599) | Provention Bio, Inc. | 2018-02-21 |
| Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis (NCT03259334) | Shire | 2018-02-09 |
| A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis (NCT03358706) | Janssen Research & Development, LLC | 2018-02-02 |
| Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis (NCT03839680) | Centre Hospitalier Universitaire de Besancon | 2018-02-01 |
| Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD (NCT03059849) | McMaster University | 2018-02-01 |
| Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis (NCT03368118) | Abivax S.A. | 2018-01-20 |
| Proteomic Analysis of Crohn's Disease Macrophages in Response or Not to AIEC (NCT03404557) | University Hospital, Clermont-Ferrand | 2018-01-18 |
| Effectiveness of Golimumab in Patients With Ulcerative Colitis: Results of a Real-life Study in Switzerland (NCT05405465) | University of Zurich | 2018-01-01 |
| Real-world Data Regarding Treatment of Ulcerative Colitis Patients With Golimumab (NCT03394586) | University of Zurich | 2018-01-01 |
| Addressing Depression and Anxiety Symptoms in Patients With Inflammatory Bowel Disease (NCT03327038) | Mount Sinai Hospital, Canada | 2018-01-01 |
| Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes Zoster (NCT03553472) | University of Wisconsin, Madison | 2018-01-01 |
| Evaluating the Combined Effect of Vedolizumab and Semi-Vegetarian Diet on Ulcerative Colitis. (NCT03309865) | Mayo Clinic | 2017-12-25 |
| A Trial of Yoga in Pediatric Inflammatory Bowel Disease (NCT03338894) | Atlantic Health System | 2017-12-13 |
| Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis (NCT03259308) | Shire | 2017-12-05 |
| Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization (NCT03182166) | Centre Hospitalier Universitaire de Saint Etienne | 2017-11-21 |
| ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis (NCT03093259) | Abivax S.A. | 2017-11-16 |
| A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission (NCT03281304) | Pfizer | 2017-11-16 |
| Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease (NCT03266484) | Massachusetts General Hospital | 2017-11-13 |
| Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) (NCT03138655) | Takeda | 2017-11-08 |
| Prevalence of Graves Disease in Patients With Ulcerative Colitis (NCT03324334) | Assiut University | 2017-11-01 |
| Stricture Definition and Treatment (STRIDENT) Observational Study. (NCT03218202) | St Vincent's Hospital Melbourne | 2017-10-09 |
| Immunological Profiles in Inflammatory Bowel Disease (NCT03366090) | Rijnstate Hospital | 2017-10-01 |
| Counseling to Optimize Adherence in Expectant Mothers With Inflammatory Bowel Disease (NCT03091309) | Mount Sinai Hospital, Canada | 2017-10-01 |
| The IMAGINE-SPOR CIHR Chronic Disease Network (NCT03131414) | Hamilton Health Sciences Corporation | 2017-10-01 |
| Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels (NCT03124121) | Guy's and St Thomas' NHS Foundation Trust | 2017-09-05 |
| Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease (NCT03397108) | The Hospital for Sick Children | 2017-08-31 |
| A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease (NCT03251118) | Target PharmaSolutions, Inc. | 2017-07-24 |
| Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis (NCT03169894) | Avalo Therapeutics, Inc. | 2017-07-14 |
| An Open Label Single-arm Phase 4 Study of Vedolizumab in Subjects With Newly Diagnosed Active Ulcerative Colitis (NCT03237260) | University of Pennsylvania | 2017-07-01 |
| The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis (NCT03178669) | InDex Pharmaceuticals | 2017-06-21 |
| Faecal Bacteriotherapy for Ulcerative Colitis (NCT03104036) | Institute for Clinical and Experimental Medicine | 2017-06-19 |
| MRI Anastomotic Integrity of Pelvic Intestinal Anastomoses (NCT04719169) | London North West Healthcare NHS Trust | 2017-06-13 |
| Study on Cannabinoid Receptor Expression in Gastrointestinal Diseases (NCT02735941) | Medical University of Graz | 2017-06-13 |
| Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC (NCT02954159) | Medical College of Wisconsin | 2017-05-18 |
| Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female Subjects (NCT03327558) | Bausch Health Americas, Inc. | 2017-05-15 |
| Restoration of the Microbiome Through Superdonor Selection (NCT03110289) | Universitaire Ziekenhuizen KU Leuven | 2017-04-30 |
| PRObiotic VSL#3® for Maintenance of Clinical and Endoscopic REMission in Ulcerative Colitis (NCT03415711) | VSL Pharmaceuticals | 2017-04-28 |
| GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation ) (NCT02994836) | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | 2017-04-21 |
| Fecal Calprotectin Collection Protocol (NCT03143517) | DiaSorin Inc. | 2017-04-19 |
| IBD Self-management Website and Home Faecal Calprotectin Monitoring (NCT03671980) | University Hospital Southampton NHS Foundation Trust | 2017-04-04 |
| The Effect of Diet on Disease Activity and Symptoms in Patients With Ulcerative Colitis (NCT03053713) | University of British Columbia | 2017-04-04 |
| Colectomy Reconstruction for Ulcerative Colitis, Ileorectal Anastomosis vs Ileal Pouch-Anal Anastomosis in Ulcerative Colitis. (NCT05628701) | Linkoeping University | 2017-04-04 |
| Fecal Microbiota Transplantation in Ulcerative Colitis (NCT03273465) | Assaf-Harofeh Medical Center | 2017-03-27 |
| Microbiota-targeted Diet for Pediatric UC (NCT02922881) | Children's Hospital of Philadelphia | 2017-03-08 |
| Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis (NCT03006809) | Najwa Elnachef | 2017-03-02 |
| The Norwegian Drug Monitoring Study (NCT03074656) | Diakonhjemmet Hospital | 2017-03-01 |
| OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome (NCT03051204) | University of California, Los Angeles | 2017-02-28 |
| Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis (NCT02914535) | Alfasigma S.p.A. | 2017-02-23 |
| Study for Safety and Tolerability of TOP1288 Administered Orally in Healthy Subjects (NCT03071081) | Topivert Pharma Ltd | 2017-02-08 |
| Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis (NCT02958865) | Pfizer | 2017-02-03 |
| VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease (NCT03257345) | University Hospital Southampton NHS Foundation Trust | 2017-02-03 |
| The Effect of Fecal Microbiota Transplantation in Ulcerative Colitis (NCT03711006) | Alice Højer Christensen | 2017-02-01 |
| A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers (NCT03038711) | Bristol-Myers Squibb | 2017-02-01 |
| Fecal Transplantation Using a Diet for Donor and Recipient in Refractory Colitis (NCT02734589) | Wolfson Medical Center | 2017-01-24 |
| Study of the Role of Pomegranate Juice Ellagitannins in the Modulation of Inflammation in Inflammatory Bowel Disease (NCT03000101) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2017-01-19 |
| Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT) (NCT02878083) | Nantes University Hospital | 2017-01-11 |
| PIBD-SETQuality: the Inception Cohort and Safety Registry (NCT03571373) | Erasmus Medical Center | 2017-01-03 |
| Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases (NCT02862132) | Shaare Zedek Medical Center | 2017-01-01 |
| Yoga for Youth With IBD: a Pilot Feasibility Study (NCT04757935) | Stanford University | 2017-01-01 |
| Predicting Clinical Response to Golimumab With Mucosal Barrier Dysfunction (NCT02729233) | University of Arkansas | 2017-01-01 |
| Specific microRNAs as Potential Biomarker for Inflammatory Bowel Disease (NCT03698500) | University Hospital Muenster | 2017-01-01 |
| An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis (NCT02808780) | Janssen Biotech, Inc. | 2016-12-16 |
| Fecal Microbiota Transplantation for Ulcerative Colitis Through Colonic Transendoscopic Enteral Tubing (NCT02998112) | The Second Hospital of Nanjing Medical University | 2016-12-01 |
| A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis (NCT02425852) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2016-12-01 |
| Golimumab Dried Blood Spot Analysis (NCT02910375) | Universitaire Ziekenhuizen KU Leuven | 2016-12-01 |
| Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis (NCT02895100) | Protagonist Therapeutics, Inc. | 2016-12-01 |
| Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGET (NCT02425865) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2016-12-01 |
| Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC (NCT02808390) | PPM Services S.A. | 2016-11-28 |
| Circadian Misalignment in Inflammatory Bowel Disease (NCT04637399) | Rush University Medical Center | 2016-11-22 |
| Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis (NCT02914522) | Gilead Sciences | 2016-11-14 |
| The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative Colitis (NCT02291523) | Children's Hospital Los Angeles | 2016-11-01 |
| The Promotion Plan of Moxibustion on Ulcerate Colitis (NCT03232528) | Shanghai Institute of Acupuncture, Moxibustion and Meridian | 2016-11-01 |
| The PRognostic Effect of Environmental Factors in Crohn's and Colitis (NCT03282903) | University of Edinburgh | 2016-11-01 |
| Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis (NCT03142113) | Universitaire Ziekenhuizen KU Leuven | 2016-11-01 |
| Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitis (NCT02962245) | Xijing Hospital of Digestive Diseases | 2016-11-01 |
| Microbiota and Immune microEnvironment in Pouchitis (NCT03136419) | University of Padova | 2016-10-31 |
| National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life (NCT02925338) | Pfizer | 2016-10-19 |
| Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC) (NCT02516384) | Weill Medical College of Cornell University | 2016-10-01 |
| Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative Colitis (NCT03018925) | Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta | 2016-10-01 |
| Fecal Transplantation in Ulcerative Colitis (NCT03561532) | Joint Authority for Päijät-Häme Social and Health Care | 2016-10-01 |
| Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative Colitis (NCT02864264) | Bristol-Myers Squibb | 2016-09-14 |
| Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis (NCT02888379) | Topivert Pharma Ltd | 2016-09-01 |
| Autoimmune Protocol Diet and Inflammatory Bowel Disease (NCT03512327) | Scripps Health | 2016-09-01 |
| Open Label Study to Assess Safety, PK and Explore Efficacy of OPRX-106 in Patients With Active Mild to Moderate Ulcerative Colitis (NCT02768974) | Protalix | 2016-09-01 |
| The Effects of Moxibustion on Ulcerative Colitis (NCT02931162) | Shanghai Institute of Acupuncture, Moxibustion and Meridian | 2016-08-23 |
| RCT: HDWL vs Virtual Chromoendoscopy in the Detection of Intraepithelial Neoplasia in Longstanding Colitis (NCT02822352) | Portsmouth Hospitals NHS Trust | 2016-08-01 |
| Ulcerative Colitis Relapse Prevention by Prebiotics (NCT02865707) | University of Alberta | 2016-08-01 |
| Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis (NCT02770040) | Austin Health | 2016-07-18 |
| A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC) (NCT02849951) | Prometheus Laboratories | 2016-07-01 |
| Fecal Microbiota Transplantation for Ulcerative Colitis (NCT03016780) | First Affiliated Hospital of Chengdu Medical College | 2016-07-01 |
| Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel Disease (NCT02846961) | Kyungpook National University Hospital | 2016-07-01 |
| Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission (NCT02365480) | National Cancer Institute (NCI) | 2016-06-16 |
| Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis (NCT02647866) | Kyowa Kirin, Inc. | 2016-06-01 |
| Efficacy of Golimumab in Maintaining Deep Remission in UC Patients in Prolonged Remission With Infliximab (NCT02868398) | Evangelismos Hospital | 2016-06-01 |
| The Clinical Value of Chromoendoscopy as Surveillance Strategy for Dysplasia Detection in Ulcerative Colitis (NCT03824418) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2016-05-09 |